Natural killer T cells and ulcerative colitis
- 1 January 2019
- journal article
- review article
- Published by Elsevier in Cellular Immunology
- Vol. 335, 1-5
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81470820, 81670497, 81370508)
- National Key Technology Research and Development Program of China (2012BA106B03)
This publication has 74 references indexed in Scilit:
- Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13Journal of Gastroenterology, 2012
- Dysregulation of CD1d-Restricted Type II Natural Killer T Cells Leads to Spontaneous Development of Colitis in MiceGastroenterology, 2012
- Cytokine dependent and independent iNKT cell activationCytokine, 2010
- Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a β-linked self-glycolipidProceedings of the National Academy of Sciences, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- The role of IL-13 and NK T cells in experimental and human ulcerative colitisMucosal Immunology, 2008
- Cross‐regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigensJournal of Cellular Physiology, 2008
- CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune systemCurrent Opinion in Immunology, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993